LU72459A1 - - Google Patents

Info

Publication number
LU72459A1
LU72459A1 LU72459A LU72459A LU72459A1 LU 72459 A1 LU72459 A1 LU 72459A1 LU 72459 A LU72459 A LU 72459A LU 72459 A LU72459 A LU 72459A LU 72459 A1 LU72459 A1 LU 72459A1
Authority
LU
Luxembourg
Application number
LU72459A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU72459A1 publication Critical patent/LU72459A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU72459A 1974-05-15 1975-05-13 LU72459A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/470,233 US3931160A (en) 1974-05-15 1974-05-15 α-Amino-α-(acylamidophenyl)acetamidocephalosporins

Publications (1)

Publication Number Publication Date
LU72459A1 true LU72459A1 (fr) 1975-08-28

Family

ID=23866778

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72459A LU72459A1 (fr) 1974-05-15 1975-05-13

Country Status (9)

Country Link
US (1) US3931160A (fr)
JP (1) JPS50154287A (fr)
BE (1) BE829025A (fr)
CH (1) CH610328A5 (fr)
DE (1) DE2521063A1 (fr)
FR (1) FR2270882B1 (fr)
GB (1) GB1457484A (fr)
LU (1) LU72459A1 (fr)
NL (1) NL7505734A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
CA1074784A (fr) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDOCEPHALOSPORINES
US4160087A (en) * 1974-09-06 1979-07-03 Sumitomo Chemical Company, Limited N-acylamino-α-arylacetamido cephalosporins
US4171362A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them
US4171368A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4171433A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Amino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporin intermediates for preparing 7-acylamino cephalosporins
US4118491A (en) * 1976-03-11 1978-10-03 Smithkline Corporation 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4082912A (en) * 1976-06-30 1978-04-04 Bristol-Myers Company Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylmethyl)-3-cephem-4-carboxylic acids their salts and easily hydrolyzed esters
US4112228A (en) * 1976-07-13 1978-09-05 Bristol-Myers Company 7-(D-α-Hydroxy-2-arylacetamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo-[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids and derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3464985A (en) * 1967-08-18 1969-09-02 Bristol Myers Co 7 - (d - alpha - amino - (acetamidophenylacetamido))-cephalosporanic acids and derivatives thereof
US3813388A (en) * 1972-01-31 1974-05-28 L Crast 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienyl-acetamido))-3-(s-(2-methyl-1,2,3-triazole-4-yl)thiomethyl)-3-cephem-4-carboxylic acids
US3776906A (en) * 1972-03-16 1973-12-04 Bristol Myers Co 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienyl-acetamido))-3-thienyl-acetamido))-3-(1,2,5-thiadiazol-3-yl)carbonylthiomethyl-3-cephem-4-carboxylic acids
US3840535A (en) * 1972-08-23 1974-10-08 Bristol Myers Co Dimethanesulfonates of certain 7-(o-aminomethylphenylacetamido)-3-((heterocyclylthio)methyl)-ceph-3-em-4-carboxylic acids

Also Published As

Publication number Publication date
JPS50154287A (fr) 1975-12-12
NL7505734A (nl) 1975-11-18
DE2521063A1 (de) 1975-11-27
FR2270882B1 (fr) 1978-08-04
FR2270882A1 (fr) 1975-12-12
BE829025A (fr) 1975-11-13
US3931160A (en) 1976-01-06
CH610328A5 (fr) 1979-04-12
GB1457484A (en) 1976-12-01

Similar Documents

Publication Publication Date Title
FI751595A (fr)
FR2269697B1 (fr)
FR2267606B1 (fr)
FR2277090B1 (fr)
FR2270882B1 (fr)
FR2284514B1 (fr)
FR2261833B1 (fr)
FR2269767B3 (fr)
AU495920B2 (fr)
AU7138274A (fr)
AU7099174A (fr)
HU170314B (fr)
FI76274A (fr)
AU482110A (fr)
AU481580A (fr)
BG26152A1 (fr)
CH1357474A4 (fr)
BG23188A1 (fr)
BG22732A1 (fr)
BG22484A1 (fr)
BG21632A1 (fr)
AU482332A (fr)
AU481457A (fr)
AU482019A (fr)
BG19828A1 (fr)